AEZS~Phase 3 Trial in Endometrial Cancer in Early
Post# of 92
Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October
http://finance.yahoo.com/news/aeterna-zentari...00737.html